Atrovent and Bydureon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent and Bydureon. Common interactions include arthralgia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Atrovent and Bydureon have. It is created by eHealthMe based on reports of 15 people who take Atrovent and Bydureon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 22, 2022

15 people who take Atrovent and Bydureon together, and have interactions are studied.


What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 27,482 Atrovent users for its effectiveness, alternative drugs and more.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 22,856 Bydureon users for its effectiveness, alternative drugs and more.

Number of Atrovent and Bydureon reports submitted per year:

Atrovent and Bydureon drug interactions.

Common Atrovent and Bydureon drug interactions by gender *:

female:

  1. Arthralgia
  2. Paronychia
  3. Pruritus
  4. Staphylococcal infection
  5. Arrhythmia
  6. Atrial fibrillation
  7. Blood glucose increased
  8. Bone pain
  9. Depression
  10. Dyspnoea

male:

  1. Chronic kidney disease
  2. Renal failure
  3. Decreased appetite
  4. Nephrogenic anaemia
  5. Deep vein thrombosis
  6. Injection site haemorrhage
  7. Nausea

Common Atrovent and Bydureon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Atrial fibrillation
  2. Deep vein thrombosis

50-59:

  1. Pruritus
  2. Staphylococcal infection
  3. Urinary tract infection
  4. Arrhythmia
  5. Chronic kidney disease
  6. Erythema
  7. Escherichia infection
  8. Escherichia test positive
  9. Impaired healing
  10. Meningitis

60+:

  1. Chronic kidney disease
  2. Decreased appetite
  3. Nephrogenic anaemia
  4. Renal failure
  5. Injection site haemorrhage
  6. Nausea

Common conditions people have *:

  1. High Blood Cholesterol: 5 people, 33.33%
  2. Immunodeficiency Common Variable: 5 people, 33.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 33.33%
  4. Pain: 4 people, 26.67%
  5. Diabetes: 4 people, 26.67%
  6. Infection: 3 people, 20.00%
  7. Inflammation: 3 people, 20.00%
  8. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 20.00%
  9. Cardiac Disorder: 3 people, 20.00%
  10. Asthma: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and Bydureon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atrovent and Bydureon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atrovent interactions:

Browse all interactions between Atrovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Bydureon interactions:

Browse all interactions between Bydureon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and exenatide synthetic (the active ingredients of Atrovent and Bydureon, respectively), and Atrovent and Bydureon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: